We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

10 hedge funds and large institutions have $1.37M invested in Tenax Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $1.31M → $1.37M (+$52.3K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

9% less funds holding

Funds holding: 11 → 10 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$66.6K
2
VKH
Virtu KCG Holdings
New York
+$49.9K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$300K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$83.2K
3
BlackRock
BlackRock
New York
-$33.3K
4
Group One Trading
Group One Trading
Illinois
-$16.6K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$676
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$751K -$83.2K -5 -14%
Millennium Management
2
Millennium Management
New York
$120K – – –
Bank of New York Mellon
3
Bank of New York Mellon
New York
$105K – – –
BBA
4
Baker Bros. Advisors
New York
$98K +$66.6K +4 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$64K – – –
VKH
6
Virtu KCG Holdings
New York
$63K +$49.9K +3 New
Northern Trust
7
Northern Trust
Illinois
$38K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$30K – – –
Verition Fund Management
9
Verition Fund Management
Connecticut
$24K – – –
DADC
10
D.A. Davidson & Co
Montana
$12K – – –
UBS Group
11
UBS Group
Switzerland
$11K – – –
WA
12
WFG Advisors
Texas
$11K – – –
Group One Trading
13
Group One Trading
Illinois
$10K -$16.6K -1 Closed
TRCT
14
Tower Research Capital (TRC)
New York
$10K – – –
BlackRock
15
BlackRock
New York
$9K -$33.3K -2 Closed
CCMINC
16
Cardinal Capital Management Inc (North Carolina)
North Carolina
$7K – – –
Morgan Stanley
17
Morgan Stanley
New York
$2K – – –
AG
18
Advisor Group
Arizona
$1K – – –
Creative Planning
19
Creative Planning
Kansas
$1K – – –
SM
20
Sabby Management
Florida
– -$300K -36 Closed
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$676 – –

TENX Hedge Fund Activity: Q2 2017 in Review

10 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2017, worth a combined $1.37M — up 4% from $1.31M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TENX and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $66.6K. The largest seller was Sabby Management, exiting entirely with an estimated $300K sold.

  • 10 institutional investors held Tenax Therapeutics (TENX) as of Q2 2017, down from 11 in Q1 2017.
  • Funds reported $1.37M of Tenax Therapeutics stock for Q2 2017, up 4% quarter-over-quarter.
  • 2 funds opened new Tenax Therapeutics positions in Q2 2017 and 3 closed out, a net change of -1 holder.
  • The largest Tenax Therapeutics buyer in Q2 2017 was Baker Bros. Advisors, an estimated $66.6K added.
  • The largest Tenax Therapeutics seller in Q2 2017 was Sabby Management, an estimated $300K sold.

Based on aggregated 13F filings for Q2 2017.